Troluce Capital Advisors LLC Cytokinetics Inc Call Options Transaction History
Troluce Capital Advisors LLC
- $826 Million
- Q2 2024
Call Options
2 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$789 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$615 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$438 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$404 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$352 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.06B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...